scispace - formally typeset
P

Patricia Griffith

Researcher at National Institutes of Health

Publications -  14
Citations -  1651

Patricia Griffith is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Thalassemia & Aplastic anemia. The author has an hindex of 11, co-authored 13 publications receiving 1602 citations.

Papers
More filters
Journal ArticleDOI

Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

TL;DR: The early use of deferoxamine in an amount proportional to the transfusional iron load reduces the body iron burden and helps protect against diabetes mellitus, cardiac disease, and early death in patients with thalassemia major.
Journal ArticleDOI

Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major

TL;DR: Variability resulting from factors other than iron status limits the clinical usefulness of the plasma ferritin concentration as a predictor of body iron stores, according to the 95% prediction intervals for hepatic iron concentration.
Journal ArticleDOI

A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases

TL;DR: Patients with pancytopenia and cellular bone marrow showed response rates similar to those of patients with chronic or moderate aplastic anemia, and patients with a variety of bone marrow failure syndromes continued to show improvement to 1 year posttreatment.
Journal ArticleDOI

Detection of early cardiac dysfunction in patients with severe beta-thalassemia and chronic iron overload.

TL;DR: In this article, the authors used radionuclide cineangiography to determine left ventricular ejection fraction during exercise in 24 patients with transfusion-dependent, congenital anemias, 21 of whom had severe beta thalassemia.
Journal ArticleDOI

Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia.

TL;DR: A combination of cyclosporine and corticosteroids may be effective therapy in patients with aplastic anaemia who have failed ATG treatment, andOccasional cases of congenital and acquired pure red cell aplasia may also respond to cyclospora.